Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven M Larson

Showing results (211-220 of 300) with videos related to

Pageof 30
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|May 9, 2013
Phase I pharmacokinetic and biodistribution study with escalating doses of ²²³Ra-dichloride in men with castration-resistant metastatic prostate cancerJorge A Carrasquillo, Joseph A O'Donoghue, Neeta Pandit-Taskar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 23, 2010
Sequential cytarabine and alpha-particle immunotherapy with bismuth-213-lintuzumab (HuM195) for acute myeloid leukemiaTodd L Rosenblat, Michael R McDevitt, Deborah A Mulford, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 23, 2017
Pharmacokinetics, Biodistribution, and Radiation Dosimetry for <sup>89</sup>Zr-Trastuzumab in Patients with Esophagogastric CancerJoseph A O'Donoghue, Jason S Lewis, Neeta Pandit-Taskar, et al.
Blood|August 1, 2002
Targeted alpha particle immunotherapy for myeloid leukemiaJoseph G Jurcic, Steven M Larson, George Sgouros, et al.
The Journal of Urology|October 19, 2013
A prospective pilot study of (89)Zr-J591/prostate specific membrane antigen positron emission tomography in men with localized prostate cancer undergoing radical prostatectomyJoseph R Osborne, David A Green, Daniel E Spratt, et al.
Annals of Surgical Oncology|September 21, 2007
Positron emission tomography detection of distant metastatic or synchronous disease in patients with locally advanced rectal cancer receiving preoperative chemoradiationCaio S R Nahas, Timothy Akhurst, Henry Yeung, et al.
The Journal of Clinical Investigation|November 23, 2011
Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activationDebyani Chakravarty, Elmer Santos, Mabel Ryder, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 23, 2020
γ-Tocotrienol-Loaded Liposomes for Radioprotection from Hematopoietic Side Effects Caused by Radiotherapeutic DrugsSang-Gyu Lee, Teja Muralidhar Kalidindi, Hanzhi Lou, et al.
Theranostics|November 16, 2018
Theranostic pretargeted radioimmunotherapy of internalizing solid tumor antigens in human tumor xenografts in mice: Curative treatment of HER2-positive breast carcinomaSarah M Cheal, Hong Xu, Hong-Fen Guo, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 26, 2021
A simple strategy to reduce the salivary gland and kidney uptake of PSMA-targeting small molecule radiopharmaceuticalsTeja Muralidhar Kalidindi, Sang-Gyu Lee, Katerina Jou, et al.
Pageof 30

Showing results (211-220 of 300) with videos related to

Sort By:
Pageof 30
European Journal of Nuclear Medicine and Molecular Imaging|May 9, 2013
Phase I pharmacokinetic and biodistribution study with escalating doses of ²²³Ra-dichloride in men with castration-resistant metastatic prostate cancerJorge A Carrasquillo, Joseph A O'Donoghue, Neeta Pandit-Taskar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 23, 2010
Sequential cytarabine and alpha-particle immunotherapy with bismuth-213-lintuzumab (HuM195) for acute myeloid leukemiaTodd L Rosenblat, Michael R McDevitt, Deborah A Mulford, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 23, 2017
Pharmacokinetics, Biodistribution, and Radiation Dosimetry for <sup>89</sup>Zr-Trastuzumab in Patients with Esophagogastric CancerJoseph A O'Donoghue, Jason S Lewis, Neeta Pandit-Taskar, et al.
Blood|August 1, 2002
Targeted alpha particle immunotherapy for myeloid leukemiaJoseph G Jurcic, Steven M Larson, George Sgouros, et al.
The Journal of Urology|October 19, 2013
A prospective pilot study of (89)Zr-J591/prostate specific membrane antigen positron emission tomography in men with localized prostate cancer undergoing radical prostatectomyJoseph R Osborne, David A Green, Daniel E Spratt, et al.
Annals of Surgical Oncology|September 21, 2007
Positron emission tomography detection of distant metastatic or synchronous disease in patients with locally advanced rectal cancer receiving preoperative chemoradiationCaio S R Nahas, Timothy Akhurst, Henry Yeung, et al.
The Journal of Clinical Investigation|November 23, 2011
Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activationDebyani Chakravarty, Elmer Santos, Mabel Ryder, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 23, 2020
γ-Tocotrienol-Loaded Liposomes for Radioprotection from Hematopoietic Side Effects Caused by Radiotherapeutic DrugsSang-Gyu Lee, Teja Muralidhar Kalidindi, Hanzhi Lou, et al.
Theranostics|November 16, 2018
Theranostic pretargeted radioimmunotherapy of internalizing solid tumor antigens in human tumor xenografts in mice: Curative treatment of HER2-positive breast carcinomaSarah M Cheal, Hong Xu, Hong-Fen Guo, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 26, 2021
A simple strategy to reduce the salivary gland and kidney uptake of PSMA-targeting small molecule radiopharmaceuticalsTeja Muralidhar Kalidindi, Sang-Gyu Lee, Katerina Jou, et al.
Pageof 30